The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of postoperative residual disease in patients with primary epithelial ovarian cancer in the era of maintenance therapies with targeted agents: A systematic review and meta-analysis.
 
Ji Hyun Kim
No Relationships to Disclose
 
Se Ik Kim
No Relationships to Disclose
 
Eun Young Park
No Relationships to Disclose
 
Hyeong In Ha
No Relationships to Disclose
 
Jae-Weon Kim
No Relationships to Disclose
 
Robert L. Coleman
Employment - US Oncology
Leadership - Onxeo
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Agenus; Alkermes; Alkermes; AstraZeneca/MedImmune; Clovis Oncology; Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; GOG Foundation; Gradalis; Immunogen; Karyopharm Therapeutics; Merck; Merck; Novocure; OncoMed; OncXerna Therapeutics
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst); Immunogen (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (I)
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Robert E. Bristow
No Relationships to Disclose
 
Sang-Yoon Park
Consulting or Advisory Role - Boryung Pharmaceuticals; Takeda Science Foundation
 
Christina Fotopoulou
Honoraria - AstraZeneca; Ethicon/Johnson & Johnson; GlaxoSmithKline; Roche/Genentech; Tesaro
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Global Oncology One; Roche/Genentech
Research Funding - Myrovlytis Trust
 
Myong Cheol Lim
Consulting or Advisory Role - AstraZeneca; Boryung; CKD Pharm; Genexine; GI Innovation; Hospicare; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma; AstraZeneca (Inst); BeiGene (Inst); Cellid (Inst); CKD pharm (Inst); Clovis Oncology (Inst); Eisai (Inst); Genexine (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Incyte (Inst); Merck (Inst); MSD (Inst); OncoQuest (Inst); Pfizer (Inst); Roche (Inst)